Effects of Intravenous L-Dopa on P300 and Regional Cerebral Blood Flow in Parkinsonism

International Journal of Neuroscience

Volumn 85, Issue 42006, 1996, Pages 147-154

  Oishi, Minoru ^a   Mochizuki, Yoko ^a   Hara, Motohiko ^a   du, Chang Mei ^a   Takasu, Toshiaki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cerebral blood flow; event related potential; L dopa; P300; parkinsonism; xenon computed tomography

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

AGED; ARTICLE; BRAIN; BRAIN CIRCULATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; ELECTROOCULOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY;

AGED; ANTIPARKINSON AGENTS; BRAIN; CEREBROVASCULAR CIRCULATION; ELECTROOCULOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030101726     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207459608986359     Document Type: Article

References (33)

1. Agniel A., Celsis P., Viallard G., Montastnic J. L., Rascol O., Demonet J. F., Marc-Vergnes J. P., Rascol A. Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. Journal of Neurology Neurosurgery and Psychiatry 1991; 54: 783 – 786
2. Brooks D. J., Ibanez V., Sawle G. V., Quinn N., Lees A. J., Mathias C. J., Bannister R., Marsden C. D., Frackowiak R. S. J. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Annals of Neurology 1990; 28: 547 – 555
3. Celsis P., Rascol O., Demonet J. F., Agniel A., Montastnic J. L., Marc-Vergnes J. P., Rascol A. Effet de la bromocriptine sur le delrit sanguin crbral dans la maladie de Parkinson. Revue Neurologique (Paris) 1988; 144: 367 – 371
4. Committee on Evoked Method Potential Examination; Japan Society of EEG and EMG. Guideline on evoked potential measurement (in Japanese). Nouha To Kindenzu 1985; 13: 97 – 104
5. Dick J. P. R., Guiloff R. J., Stewart A., Blackstock J., Bielawska C, Paul E. A., Marsden C. D. Mini-mental state examination in neurological patients. Journal of Neurology Neurosurgery and Psychiatry 1984; 47: 496 – 499
6. Folstein M. F., Folstein S. E., McHugh P. R. “Mini-mental state” a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975; 12: 189 – 198
7. Gil R, Neau Ph J., Toullat G., Rivasseau-Jonveaux Th., Lefevre J. P. Maladie de Parkinson et potentials évoqués cognitifs. Revue Neurologique (Paris) 1989; 145: 201 – 207
8. Goodin D. S., Aminoff M. J. Electrophysiological differences between demented and nondemented patients with Parkinson's disease. Annals of Neurology 1987; 21: 90 – 94
9. Graham J. S., Yiannikas C, Gordon E., Coyle S., Morris J. G. L. P300 event-related potentials in de novo Parkinson's disease. Clinical and Experimental Neurology 1990; 27: 89 – 98
10. Hansch E. C, Syndulko K., Cohen S. N., Goldberg Z. I., Potvin A. R., Tourtellotte W. W. Cognition in Parkinson disease: an event-related potential perspective. Annals of Neurology 1982; 11: 599 – 607
11. Hanafusa H., Motomura N., Fukai M. Event-related potentials in senile dementia of Alzheimer's type, multiinfarct dementia and Parkinson's disease. Japanese Journal of Psychiatry and Neurology 1991; 5: 667 – 670
12. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427 – 442
13. Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology Neurosurgery and Psychiatry 1992; 55: 181 – 184
14. Ito J. Somatosensory event-related potentials (ERPs) in patients with different types of dementia. Journal of Neurological Sciences 1994; 121: 139 – 146
15. Jagust W. J., Reed B. R., Martin E. M., Eberling J. L., Nelson-Abbott R. A. Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain 1992; 115: 521 – 537
16. Johnson D. W., Stringer W. A., Marks M. P., Yonas H., Good W. F., Gur D. Stable xenon CT cerebral blood flow imaging: rationale for and role in clinical decision making. American Journal of Neuroradiology 1991; 12: 201 – 213
17. Kashiwagi S., Yamashita T., Nakano S., Kalender W., Polacin A., Takasago T., Eguchi Y., Ito H. The wash-in/washout protocol in stable xenon CT cerebral blood flow studies. American Journal of Neuroradiology 1992; 13: 49 – 53
18. Kimura I., Ohnuma A., Seki H., Saso S., Kogure K. Cognitive impairment in Parkinson's disease assessed by visuomotor performance system and P300 potential. Tohoku Journal of Experimental Medicine 1990; 161: 155 – 165, suppl
19. Kitamura S., Ujike T., Kuroki S., Sakamoto S., Soeda T., Iio M., Terashi A. Cerebral blood flow and oxygen metabolism in patients with Parkinson's disease (in Japanese). No To Shinkei 1988; 40: 979 – 985
20. Kobari M., Fukuuchi Y., Shinohara T., Nogawa S., Takahashi K. Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy: comparison with Parkinson's disease. Archives of Neurology 1992; 49: 725 – 730
21. Leenders K. L., Wolfson L., Gibbs J. M., Wise R. J. S., Causon R., Jones T., Legg N. J. The effects of L-dopa on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. Brain 1985; 108: 171 – 191
22. Montastruc J. L., Celsis P., Agniel A., Demonet J. F., Doyon B., Puel M, Marc-Vergnes J. P., Rascol A. Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements. Movement Disorders 1987; 2: 279 – 289
23. Pizzolato G., Dam M., Borsato N., Saitta B., Da Col C, Perlotto N. M., Zanco P., Ferlin G., Battistin L. [99mTc]-HM-PAO SPECT in Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism 1988; 8: S101 – S108
24. Prasher D., Findley L. Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation. Journal of Neurology Neurosurgery and Psychiatry 1991; 54: 603 – 609
25. Sawada H., Udaka F., Kameyama M., Seriu N., Nishinaka K., Shindou K., Kodama M., Nishitani N., Okumiya K. SPECT findings in Parkinson's disease associated with dementia. Journal of Neurology Neurosurgery and Psychiatry 1992; 55: 960 – 963
26. Shindo H., Nakajima E., Kawai K., Miyakoshi N., Tanaka K. Studies on the metabolism of D- and L-isomers of 3, 4-dihydroxyphenylalanine (DOPA). III. absorption, distribution and excretion of D- and L-DOPA-14C in rats following intravenous and oral administration. Chemical and Pharmaceutical Bulletin 1973; 21: 817 – 825
27. Stanzione P., Fattapposta F., Giunti P., D'Alessio C, Tagliati M., Affricano C., Amabile G. P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroencephalography and clinical Neurophysiology 1991; 80: 446 – 453
28. Stanzione P., Fattapposta F., Tagliati M., D'Alessio C, Marciani M. G., Foti A., Amabile G. Dopaminergic pharmacological manipulations in normal humans confirm the specificity of the visual (PERG-VEP) and cognitive (P300) electrophysiological alterations in Parkinson's disease. Electroencephalography and clinical Neurophysiology Supplement 1990; 41: 216 – 220
29. Starkstein S. E., Esteguy M, Berthier M. L., Garcia H., Leiguarda R. Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 1989; 52: 338 – 340
30. Tachibana H., Takeda M., Sugita M. Electrophysiological differences between Parkinson's disease and vascular parkinsonism. Japanese Journal of Medicine 1988; 27: 261 – 266
31. Toda K., Tachibana H., Sugita M., Konishi K. P300 and reaction time in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology 1993; 6: 131 – 136
32. Touho H., Karasawa J., Shishido H., Yamada K. Clinical application of stable xenon CT-CBF studies without denitrogenation. Neurologica Medica Chirurugica (Tokyo) 1990; 30: 569 – 574
33. Wang S-J., Liu R-S., Liu H-C, Lin K., Shan D., Liao K., Fuh J., Lee L. Technetium-99m hexam-ethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization. European Journal of Nuclear Medicine 1993; 20: 339 – 344